Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, National Cancer Institute of Canada Clinical Trials Group (2005) European Organisation for Research and Treatment of Cancer Brain Tumor Radiotherapy Groups, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987–996 https://doi.org/10.1056/NEJMoa043330

van den Bent MJ, Tesileanu CMS, Wick W, Sanson M, Brandes AA, Clement PM, Erridge S, Vogelbaum MA, Nowak AK, Baurain JF, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Rogers L, Taal W, Ruda R, Weller M, McBain C, Reijneveld J, Enting RH, Caparrotti F, Lesimple T, Clenton S, Gijtenbeek A, Lim E, Herrlinger U, Hau P, Dhermain F, de Heer I, Aldape K, Jenkins RB, Dubbink HJ, Kros JM, Wesseling P, Nuyens S, Golfinopoulos V, Gorlia T, French P, Baumert BG (2021) Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053– 22054): second interim analysis of a randomised, open-label, phase 3 study. Lancet Oncol 22:813–823. https://doi.org/10.1016/S1470-2045(21)00090-5

Article  PubMed  PubMed Central  Google Scholar 

Grossman SA, Desideri S, Ye X, Szajna K, Chamberlain M, Lesser G (2007) Iatrogenic immunosuppression in patients with newly diagnosed high-grade gliomas. J Clin Oncol 25:2012–2012. https://doi.org/10.1200/jco.2007.25.18_suppl.2012

Article  Google Scholar 

Grossman SA, Ye X, Lesser G, Sloan A, Carraway H, Desideri S, Piantadosi S, Consortium NC (2011) Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clin Cancer Res 17:5473–5480. https://doi.org/10.1158/1078-0432.CCR-11-0774

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahindra AK, Grossman SA (2003) Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors. J Neurooncol 63:263–270. https://doi.org/10.1023/a:1024217527650

Article  PubMed  Google Scholar 

Merck & Co (2016) Temozolomide [package insert]. Whitehouse Station, NJ

Google Scholar 

Cohen MH, Johnson JR, Pazdur R (2005) Food and Drug Administration Drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme. Clin Cancer Res 11:6767–6771. https://doi.org/10.1158/1078-0432.CCR-05-0722

Article  CAS  PubMed  Google Scholar 

Hirschel B, Lazzarin A, Chopard P, Opravil M, Furrer HJ, Ruttimann S, Vernazza P, Chave JP, Ancarani F, Gabriel V et al (1991) A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med 324:1079–1083. https://doi.org/10.1056/NEJM199104183241602

Article  CAS  PubMed  Google Scholar 

Schneider MM, Hoepelman AI, Eeftinck Schattenkerk JK, Nielsen TL, van der Graaf Y, Frissen JP, van der Ende IM, Kolsters AF, Borleffs JC (1992) A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. N Engl J Med 327:1836–1841. https://doi.org/10.1056/NEJM199212243272603

Article  CAS  PubMed  Google Scholar 

Gerber DE, Grossman SA, Zeltzman M, Parisi MA, Kleinberg L (2007) The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas. Neuro Oncol 9:47–52. https://doi.org/10.1215/15228517-2006-024

Article  CAS  PubMed  PubMed Central  Google Scholar 

Climans SA, Grunfeld E, Mason WP, Chan KKW (2022) Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy. Neuro Oncol 24:1738–1748. https://doi.org/10.1093/neuonc/noac072

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singhal N, Selva-Nayagam S, Brown MP (2007) Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature. J Neurooncol 85:229–230. https://doi.org/10.1007/s11060-007-9403-6

Article  CAS  PubMed  Google Scholar 

Hoffmann-LaRoche (2013) Bactrim™: sulfamethoxazole and trimethoprim DS (double-strength) tablets and tablets USP. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/017377s074lbl.pdf

Elajez R, Adeli M (2018) Myelosuppression effect of trimethoprim-sulfamethoxazole prophylaxis in innate immune defect patients: retrospective comparative study. J Allergy Clin Immunol 141:AB25. https://doi.org/10.1016/j.jaci.2017.12.078

Article  Google Scholar 

Lexicomp (n.d.) Pentamidine (oral inhalation): drug information. https://www.uptodate.com/contents/pentamidine-oral-inhalation-drug-information?search=pentamidine&source=panel_search_result&selectedTitle=1~58&usage_type=panel&showDrugLabel=true&display_rank=1#F44486498. Accessed January 13 2024

Walker JG, Kadia T, Brown L, Juneja HS, de Groot JF (2009) Dapsone induced methemoglobinemia in a patient with glioblastoma. J Neurooncol 94:149–152. https://doi.org/10.1007/s11060-009-9813-8

Article  PubMed  PubMed Central  Google Scholar 

Mitta A, Curtis BR, Reese JA, George JN (2019) Drug-induced thrombocytopenia: 2019 update of clinical and laboratory data. Am J Hematol 94:E76–E78. https://doi.org/10.1002/ajh.25379

Article  PubMed  Google Scholar 

Armstrong TS, Cao Y, Scheurer ME, Vera-Bolanos E, Manning R, Okcu MF, Bondy M, Zhou R, Gilbert MR (2009) Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors. Neuro Oncol 11:825–832. https://doi.org/10.1215/15228517-2008-120

Article  CAS  PubMed  PubMed Central  Google Scholar 

Henson JW, Jalaj JK, Walker RW, Stover DE, Fels AO (1991) Pneumocystis carinii pneumonia in patients with primary brain tumors. Arch Neurol 48:406–409. https://doi.org/10.1001/archneur.1991.00530160074017

Article  CAS  PubMed  Google Scholar 

Neuwelt AJ, Nguyen TM, Fu R, Bubalo J, Tyson RM, Lacy C, Gahramanov S, Nasseri M, Barnes PD, Neuwelt EA (2014) Incidence of Pneumocystis Jirovecii pneumonia after temozolomide for CNS malignancies without prophylaxis. CNS Oncol 3:267–273. https://doi.org/10.2217/cns.14.24

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rifino N, Rigamonti A, Guida FM, De Nobili G, Spena G, Ferrarese C, Salmaggi A (2019) Lack of development of Pneumocystis Jirovecii Pneumonia in a cohort of 103 Italian glioblastoma patients not receiving prophylaxis during post-surgical chemoradiotherapy. J Neurol Sci 405:116431. https://doi.org/10.1016/j.jns.2019.116431

Article  PubMed  Google Scholar 

Skorupan N, Ranjan S, Mehta S, Yankulina O, Nenortas N, Grossman S, Ye X, Holdhoff M (2019) Pneumocystis jirovecii prophylaxis in patients treated for high-grade gliomas: a survey among neuro-oncologists. Neurooncol Pract 6:321–326. https://doi.org/10.1093/nop/npy049

Article  PubMed  Google Scholar